An underground market for unlicensed weight-loss medications is propelled by social media fitness personalities and sellers on messaging platforms, based on new investigations.
Experimental Treatment Gaining Popularity Via Social Media
The experimental drug, which is still in research studies, is being promoted by social media influencers for its alleged fat-burning properties. Followers are urged to message these accounts privately for source information, while also receiving promotional offers.
Active Trade on Social Networks
Separately, a robust market exists on Telegram, where communities with thousands of members share comparison photos, injection guides and claims of rapid UK delivery. Sellers market the substance there before directing customers to other platforms for purchases.
Learning About Retatrutide
Retatrutide is an experimental injection created by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could assist patients reduce up to 25% of their total weight. Referred to as the “triple G”, the substance is being promoted digitally as the next Ozempic.
Healthcare Professionals Express Worries
Nevertheless, doctors and pharmacists have warned that the sale of what remains an unapproved medication in the UK is a cause for concern and could result in users administering products of uncertain source.
Some experts stated the demand for retatrutide could be linked to the rising price of approved weight loss treatments such as Mounjaro.
Regulatory Status and Enforcement
Selling retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unlicensed drug that cannot be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.
Some influencers attempt to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still violate medicines, advertising, and customer regulations, risking penalties, legal action or imprisonment.
Platform Reaction and Material Elimination
Based on the social media company, the service has taken down violative content and prohibited associated hashtags and search suggestions. The organization said it was dedicated to maintaining the platform safe and investing in strengthening enforcement strategies.
Online Marketplace Operations
Research also found communities with up to 9,000 members marketing retatrutide using the platform's built-in search feature, which operates like a online catalog. Entering “retatrutide” immediately displays channels with thousands of users, populated with photos of weight loss, positive reviews and detailed guides for mixing or administering at residence.
Within moments of joining one group, a vendor posted contact information, where most transactions occur. The seller provided an guidebook and promised delivery within 48 hours. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None asked about body mass, medical conditions or previous experience.
Product Information and Costs
Inside these communities, messages display black plastic parcels with Royal Mail labels, claiming to include new batches. One communication stated: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, prepared at residence with purified liquid, or ready-to-use injectors typically priced at 160 pounds for 20 milligrams. When asked how long a injector should be used, vendors give contradictory answers varying between a several days to “depends on your body”.
Platform Oversight and Safety Actions
A spokesperson for Telegram said it regularly monitored harmful material on its platform including material that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Cautions
“People are administering materials they cannot confirm. Even if the science behind retatrutide is sound, these digital versions may not contain what they advertise,” stated Jason Murphy, the head of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of an online medical service linked the increase in demand to current price rises for approved weight-loss medications such as Mounjaro. “With costs increasing, patients are using social media. But fake injections are extremely risky. You can’t be certain what’s contained or whether the environment they were produced in was clean,” she said.
Her staff has already encountered individuals injured by self-injection from unverified suppliers. “We understand the frustration, but buying from Telegram or WhatsApp is taking chances with your health,” stated Wyllie. “These materials could be contaminated or incorrectly dosed.”
Producer Statement
A representative from Eli Lilly stated the substance was in third stage research studies and had not been evaluated or authorized by any government authority anywhere in the world. “Therefore at this point no one can sell [it] for personal consumption,” they said, adding that any item “falsely representing itself as a company investigational product not yet authorized … may subject users to possibly significant medical dangers”.
